Increased GABA contributes to enhanced control over motor excitability in Tourette syndrome

Amelia Draper, Mary C Stephenson, Georgina M Jackson, Sophia Pépés, Paul S Morgan, Peter G Morris, Stephen R Jackson, Amelia Draper, Mary C Stephenson, Georgina M Jackson, Sophia Pépés, Paul S Morgan, Peter G Morris, Stephen R Jackson

Abstract

Tourette syndrome (TS) is a developmental neurological disorder characterized by vocal and motor tics and associated with cortical-striatal-thalamic-cortical circuit dysfunction, hyperexcitability within cortical motor areas, and altered intracortical inhibition. TS often follows a developmental time course in which tics become increasingly more controlled during adolescence in many individuals, who exhibit enhanced control over their volitional movements. Importantly, control over motor outputs appears to be brought about by a reduction in the gain of motor excitability. Here we present a neurochemical basis for a localized gain control mechanism. We used ultra-high-field (7 T) magnetic resonance spectroscopy to investigate in vivo concentrations of γ-aminobutyric acid (GABA) within primary and secondary motor areas of individuals with TS. We demonstrate that GABA concentrations within the supplementary motor area (SMA)--a region strongly associated with the genesis of motor tics in TS--are paradoxically elevated in individuals with TS and inversely related to fMRI blood oxygen level-dependent activation. By contrast, GABA concentrations in control sites do not differ from those of a matched control group. Importantly, we also show that GABA concentrations within the SMA are inversely correlated with cortical excitability in primary motor cortex and are predicted by motor tic severity and white-matter microstructure (FA) within a region of the corpus callosum that projects to the SMA within each hemisphere. Based upon these findings, we propose that extrasynaptic GABA contributes to a form of control, based upon localized tonic inhibition within the SMA, that may lead to the suppression of tics.

Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Figures

Figure 1
Figure 1
Results of Brain Imaging Analyses (A) The fMRI BOLD signal associated with a bimanual sequential finger-thumb opposition task (tap > rest contrast) for a single representative participant that, for presentation purposes only, has been spatially smoothed. (B) Mean GABA/NAA ratios for the Tourette syndrome (TS) and control group (CS) for each ROI. For the SMA ROI only, GABA concentrations are elevated relative to controls (∗p < 0.05). Error bars are standard deviation. (C) Scatterplot showing the negative association (r = −0.63, p 

Figure 2

Association between SMA GABA Concentration…

Figure 2

Association between SMA GABA Concentration and Motor Excitability Individual levels of GABA concentration…

Figure 2
Association between SMA GABA Concentration and Motor Excitability Individual levels of GABA concentration within the SMA ROI are inversely related to motor excitability immediately prior (81%–100%) to the execution of volitional movements. Motor excitability was measured by recording motor evoked potentials from the right hand following single-pulse TMS delivered to the left primary motor cortex. See Supplemental Information for further details.

Figure 3

Association between SMA GABA Concentration…

Figure 3

Association between SMA GABA Concentration and WM Microstructure (Ai and Aii) An example…

Figure 3
Association between SMA GABA Concentration and WM Microstructure (Ai and Aii) An example ROI located in the SMA, displayed in the axial (Ai) and sagittal (Aii) planes. (Aiii) Fibers tracked from the SMA region (red) and the location of the 6 mm3 ROI located within the body of the corpus callosum where the fibers cross between the hemispheres (blue). (Aiv) Confirmation that fibers tracked from the central 6 mm3 ROI located within the corpus callosum terminate within the SMA. (B) Scatterplot showing the significant positive association (r = 0.87, p 
Comment in
Similar articles
Cited by
References
    1. Leckman J.F. Tourette’s syndrome. Lancet. 2002;360:1577–1586. - PubMed
    1. Kalanithi P.S., Zheng W., Kataoka Y., DiFiglia M., Grantz H., Saper C.B., Schwartz M.L., Leckman J.F., Vaccarino F.M. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc. Natl. Acad. Sci. USA. 2005;102:13307–13312. - PMC - PubMed
    1. Albin R.L., Mink J.W. Recent advances in Tourette syndrome research. Trends Neurosci. 2006;29:175–182. - PubMed
    1. Orth M., Rothwell J.C. Motor cortex excitability and comorbidity in Gilles de la Tourette syndrome. J. Neurol. Neurosurg. Psychiatry. 2009;80:29–34. - PubMed
    1. Gilbert D.L., Bansal A.S., Sethuraman G., Sallee F.R., Zhang J., Lipps T., Wassermann E.M. Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome. Mov. Disord. 2004;19:416–425. - PubMed
Show all 38 references
Publication types
Substances
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 2
Figure 2
Association between SMA GABA Concentration and Motor Excitability Individual levels of GABA concentration within the SMA ROI are inversely related to motor excitability immediately prior (81%–100%) to the execution of volitional movements. Motor excitability was measured by recording motor evoked potentials from the right hand following single-pulse TMS delivered to the left primary motor cortex. See Supplemental Information for further details.
Figure 3
Figure 3
Association between SMA GABA Concentration and WM Microstructure (Ai and Aii) An example ROI located in the SMA, displayed in the axial (Ai) and sagittal (Aii) planes. (Aiii) Fibers tracked from the SMA region (red) and the location of the 6 mm3 ROI located within the body of the corpus callosum where the fibers cross between the hemispheres (blue). (Aiv) Confirmation that fibers tracked from the central 6 mm3 ROI located within the corpus callosum terminate within the SMA. (B) Scatterplot showing the significant positive association (r = 0.87, p 

References

    1. Leckman J.F. Tourette’s syndrome. Lancet. 2002;360:1577–1586.
    1. Kalanithi P.S., Zheng W., Kataoka Y., DiFiglia M., Grantz H., Saper C.B., Schwartz M.L., Leckman J.F., Vaccarino F.M. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc. Natl. Acad. Sci. USA. 2005;102:13307–13312.
    1. Albin R.L., Mink J.W. Recent advances in Tourette syndrome research. Trends Neurosci. 2006;29:175–182.
    1. Orth M., Rothwell J.C. Motor cortex excitability and comorbidity in Gilles de la Tourette syndrome. J. Neurol. Neurosurg. Psychiatry. 2009;80:29–34.
    1. Gilbert D.L., Bansal A.S., Sethuraman G., Sallee F.R., Zhang J., Lipps T., Wassermann E.M. Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome. Mov. Disord. 2004;19:416–425.
    1. Orth M., Münchau A., Rothwell J.C. Corticospinal system excitability at rest is associated with tic severity in tourette syndrome. Biol. Psychiatry. 2008;64:248–251.
    1. Heise K.F., Steven B., Liuzzi G., Thomalla G., Jonas M., Müller-Vahl K., Sauseng P., Münchau A., Gerloff C., Hummel F.C. Altered modulation of intracortical excitability during movement preparation in Gilles de la Tourette syndrome. Brain. 2010;133:580–590.
    1. Mueller S.C., Jackson G.M., Dhalla R., Datsopoulos S., Hollis C.P. Enhanced cognitive control in young people with Tourette’s syndrome. Curr. Biol. 2006;16:570–573.
    1. Jackson G.M., Mueller S.C., Hambleton K., Hollis C.P. Enhanced cognitive control in Tourette Syndrome during task uncertainty. Exp. Brain Res. 2007;182:357–364.
    1. Jung J., Jackson S.R., Parkinson A., Jackson G.M. Cognitive control over motor output in Tourette syndrome. Neurosci. Biobehav. Rev. 2013;37:1016–1025.
    1. Jung J., Jackson S.R., Nam K., Hollis C., Jackson G.M. Enhanced saccadic control in young people with Tourette syndrome despite slowed pro-saccades. J. Neuropsychol. 2014 doi: 10.1111/jnp.12044. Published online April 16, 2014.
    1. Jackson S.R., Parkinson A., Manfredi V., Millon G., Hollis C., Jackson G.M. Motor excitability is reduced prior to voluntary movements in children and adolescents with Tourette syndrome. J. Neuropsychol. 2013;7:29–44.
    1. Draper A., Jude L., Jackson G.M., Jackson S.R. Motor excitability during movement preparation in Tourette syndrome. J. Neuropsychol. 2013 doi: 10.1111/jnp.12033. Published online November 28, 2013.
    1. Bohlhalter S., Goldfine A., Matteson S., Garraux G., Hanakawa T., Kansaku K., Wurzman R., Hallett M. Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. Brain. 2006;129:2029–2037.
    1. Ramamoorthi K., Lin Y. The contribution of GABAergic dysfunction to neurodevelopmental disorders. Trends Mol. Med. 2011;17:452–462.
    1. Clarke R.A., Lee S., Eapen V. Pathogenetic model for Tourette syndrome delineates overlap with related neurodevelopmental disorders including Autism. Transl. Psychiatr. 2012;2:e158.
    1. Lerner A., Bagic A., Simmons J.M., Mari Z., Bonne O., Xu B., Kazuba D., Herscovitch P., Carson R.E., Murphy D.L. Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome. Brain. 2012;135:1926–1936.
    1. Plessen K.J., Wentzel-Larsen T., Hugdahl K., Feineigle P., Klein J., Staib L.H., Leckman J.F., Bansal R., Peterson B.S. Altered interhemispheric connectivity in individuals with Tourette’s disorder. Am. J. Psychiatry. 2004;161:2028–2037.
    1. Serrien D.J., Orth M., Evans A.H., Lees A.J., Brown P. Motor inhibition in patients with Gilles de la Tourette syndrome: functional activation patterns as revealed by EEG coherence. Brain. 2005;128:116–125.
    1. Jackson S.R., Parkinson A., Jung J., Ryan S.E., Morgan P.S., Hollis C., Jackson G.M. Compensatory neural reorganization in Tourette syndrome. Curr. Biol. 2011;21:580–585.
    1. Akkal D., Dum R.P., Strick P.L. Supplementary motor area and presupplementary motor area: targets of basal ganglia and cerebellar output. J. Neurosci. 2007;27:10659–10673.
    1. Nachev P., Kennard C., Husain M. Functional role of the supplementary and pre-supplementary motor areas. Nat. Rev. Neurosci. 2008;9:856–869.
    1. Sumner P., Nachev P., Morris P., Peters A.M., Jackson S.R., Kennard C., Husain M. Human medial frontal cortex mediates unconscious inhibition of voluntary action. Neuron. 2007;54:697–711.
    1. Boy F., Evans C.J., Edden R.A., Singh K.D., Husain M., Sumner P. Individual differences in subconscious motor control predicted by GABA concentration in SMA. Curr. Biol. 2010;20:1779–1785.
    1. Franzkowiak S., Pollok B., Biermann-Ruben K., Südmeyer M., Paszek J., Thomalla G., Jonas M., Orth M., Münchau A., Schnitzler A. Motor-cortical interaction in Gilles de la Tourette syndrome. PLoS ONE. 2012;7:e27850.
    1. Mantovani A., Lisanby S.H., Pieraccini F., Ulivelli M., Castrogiovanni P., Rossi S. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette’s syndrome (TS) Int. J. Neuropsychopharmacol. 2006;9:95–100.
    1. Kwon H.J., Lim W.S., Lim M.H., Lee S.J., Hyun J.K., Chae J.H., Paik K.C. 1-Hz low frequency repetitive transcranial magnetic stimulation in children with Tourette’s syndrome. Neurosci. Lett. 2011;492:1–4.
    1. Le K., Liu L., Sun M., Hu L., Xiao N. Transcranial magnetic stimulation at 1 Hertz improves clinical symptoms in children with Tourette syndrome for at least 6 months. J. Clin. Neurosci. 2013;20:257–262.
    1. Stagg C.J., Bachtiar V., Johansen-Berg H. The role of GABA in human motor learning. Curr. Biol. 2011;21:480–484.
    1. Stagg C.J., Bestmann S., Constantinescu A.O., Moreno L.M., Allman C., Mekle R., Woolrich M., Near J., Johansen-Berg H., Rothwell J.C. Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex. J. Physiol. 2011;589:5845–5855.
    1. Stagg C.J. Magnetic Resonance Spectroscopy as a tool to study the role of GABA in motor-cortical plasticity. Neuroimage. 2014;86:19–27.
    1. Farrant M., Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat. Rev. Neurosci. 2005;6:215–229.
    1. Koch U., Magnusson A.K. Unconventional GABA release: mechanisms and function. Curr. Opin. Neurobiol. 2009;19:305–310.
    1. Roth F.C., Draguhn A. GABA metabolism and transport: effects on synaptic efficacy. Neural Plast. 2012;2012:805830.
    1. Héja L., Nyitrai G., Kékesi O., Dobolyi A., Szabó P., Fiáth R., Ulbert I., Pál-Szenthe B., Palkovits M., Kardos J. Astrocytes convert network excitation to tonic inhibition of neurons. BMC Biol. 2012;10:26.
    1. Donahue M.J., Near J., Blicher J.U., Jezzard P. Baseline GABA concentration and fMRI response. Neuroimage. 2010;53:392–398.
    1. Muthukumaraswamy S.D., Edden R.A.E., Jones D.K., Swettenham J.B., Singh K.D. Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans. Proc. Natl. Acad. Sci. USA. 2009;106:8356–8361.
    1. Plessen K.J., Grüner R., Lundervold A., Hirsch J.G., Xu D., Bansal R., Hammar A., Lundervold A.J., Wentzel-Larsen T., Lie S.A. Reduced white matter connectivity in the corpus callosum of children with Tourette syndrome. J. Child Psychol. Psychiatry. 2006;47:1013–1022.

Source: PubMed

3
Abonnere